Search - tctmd.com

Displaying 41 - 60 of 83

Sort: Relevancy | Date

Presentation TCT 2015

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Yaling Han

October 13, 2015

Presentation TCT 2015

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Bo Xu

October 13, 2015

Presentation CCVVC 2015

Stents with Biodegradable Polymer

Presenter: Augusto Pichard

June 19, 2015

Presentation EuroPCR 2015

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Presenter: Masahiro Natsuaki

May 19, 2015

Presentation AHA 2014

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

Presenter: C.Kaiser

November 16, 2014

Presentation TCT 2014

TCT 15: Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent in Patients Undergoing Primary Percutaneous Coronary Intervention: 3-Year Follow-up From the COMPARE II Trial

Presenter: John M. Lasala, Stuart J. Pocock, Georgios Vlachojannis, MD

September 16, 2014

Presentation TCT 2014

I-LOVE-IT 2: A Prospective, Randomized Trial of a Biodegradable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent Versus a Durable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Bo Xu

September 16, 2014

Presentation TCT 2014

Comparison of sirolimus-eluting stents with biodegradable polymer versus zotarolimus-eluting stents with durable polymer assessed by optical coherence tomography: The ALSTER-OCT___

Presenter: Christian Heeger

September 16, 2014

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Presenter: Guy F Prado Jr

September 16, 2014

Presentation TCT 2014

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Ran Kornowski

September 15, 2014

Presentation TCT 2014

TCT 584: Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus Durable Polymer, Everolimus-Eluting Stent: 3-Year Follow-up from the COMPARE II Trial

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil

September 15, 2014

Presentation TCT 2014

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

Presenter: Pieter C. Smits

September 14, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Presenter: Valentin Fuster, Pieter C. Smits

September 13, 2014

Presentation ESC 2014

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

Presenter: Thomas Pilgrim

September 01, 2014

Presentation ACC 2014

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 31, 2014

Presentation CIT 2014

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

Presenter: Han Yaling

March 22, 2014

Presentation TCT 2013

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

Presenter: Yelin Zhao

October 29, 2013

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

Advertisement

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Stents with Biodegradable Polymer

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

TCT 15: Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent in Patients Undergoing Primary Percutaneous Coronary Intervention: 3-Year Follow-up From the COMPARE II Trial

I-LOVE-IT 2: A Prospective, Randomized Trial of a Biodegradable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent Versus a Durable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

Comparison of sirolimus-eluting stents with biodegradable polymer versus zotarolimus-eluting stents with durable polymer assessed by optical coherence tomography: The ALSTER-OCT___

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

TCT 584: Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus Durable Polymer, Everolimus-Eluting Stent: 3-Year Follow-up from the COMPARE II Trial

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content